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List of Abbreviations:  
ASGC: Australian Standard Geographical Classification 
CBH: Cairns Base Hospital 
GP: General Practitioner 
Indigenous patients: Patients of Aboriginal and Torres Strait Islander Origin. 
MBH: Mackay Base Hospital  
RA: Remoteness Areas 
TAFE: Technical and further education 
TCC: Townsville Cancer Centre 












Introduction: Aims of this study were to examine time delays in lung cancer referral 
pathways in North Queensland (NQ), Australia, and explore patients’ perspective of factors 
causing these delays.  
Methods: Prospective study of patients attending three cancer centres in Townsville, Cairns 
and Mackay in NQ from 2009 to 2012. Times along referral pathway were divided as follows: 
Onset of symptoms to treatment (T1), symptoms to general practitioner(GP) (T2), GP to 
specialist (T3), and Specialist to treatment (T4). Quantitative and qualitative methods were 
used for analysis. 
Results:  252 patients participated. T1 was influenced by remoteness (125 days in 
Townsville vs. 170 days for Remote, p=0.01), T2 by level of education (91 days for Primary 
education vs. 61 days for Secondary vs. 23 days for Tertiary/TAFE, p=0.006), and age group 
(14 days for 31-50 years, 61 days for 51-70 years, 45 days for >71 years, p=0.026), T3 by 
remoteness (15 days for Townville and 29.5 days for remote, p=0.02) and T4 by stage of 
disease (21 days for stage I, 11 days for Stage II, 34 days for Stage III 18 days for Stage IV, 
p=0.041). Competing priorities of family and work and cost & inconvenience of travel were 
perceived as rural barriers.  
Conclusion: Remoteness, age and level of education were related to delays in various time 
lines in lung cancer referral pathways in NQ. Provision of specialist services closer to home 









Lung cancer has been the leading cause of death due to cancer in Australia. Disparity in lung 
cancer survival rates between rural and urban areas has been well documented worldwide. In 
Australia, the 5-year survival for lung cancer in urban areas was 15% compared to 13% in 
inner regional and 11% in outer regional and remote Australia.
1
 In addition, Indigenous 






Lower survival among rural patients could be due to many factors including delays in 
diagnosis, advanced disease at presentation, delays in initiation of treatment, higher 
proportion of indigenous populations in rural areas and lower uptake of medical therapies. A 
study from Western Australia reported that rural patients reported more symptoms and took 
longer to consult their general practitioners (GPs) compared with their metropolitan 
counterparts. This often led to later diagnosis. They also experienced longer waits for 
specialist consultations and underwent less diagnostic testings, raising concerns regarding 
equity and quality of lung cancer care for rural patients.
3
 In a Scottish study, lung cancer 










patients living more than 58kms from a cancer centre were more likely to present with later 




In the Australian state of Victoria, it was found that radiotherapy and chemotherapy were 
under-utilized by patients, and 26% of patients did not receive any treatment for their Lung 
Cancer. Patients whose cases were discussed at a multidisciplinary meeting (MDM) were 
significantly more likely to receive anticancer treatment and had longer survival.
5
 In another 
recent Victorian study, it was found that there were significant delays at various stages of 
patients’ journey from the first presentation to treatment commencement, and patients treated 
at public hospitals experienced longer delays than those attending private hospitals.
6
 A 
Queensland study comparing the survival of indigenous and non-indigenous patients 
receiving treatment for lung cancer found that indigenous patients had a lower survival rate 
even after adjusting for histological subtype, stage at diagnosis and co-morbidities.
7 
 
Although these studies have established the presence of survival disparity between rural and 
urban populations and the impact of delays in medical consultations or treatment on survival, 
most of them were retrospective in nature and studies examining possible reasons for such 
delays were limited. Therefore, prospective studies examining referral patterns are required 
for understanding these delays. 
 
In North Queensland, where this study was conducted, patients from rural areas may travel 
distances up to 1000km to access specialist care and may be referred to one of the three 
centres, namely Townsville, Cairns and Mackay for diagnostic work-up and further 
management. Townsville provided comprehensive cancer services including cardiothoracic 
surgery in private and public sectors. Cairns offered radiotherapy services and Mackay had 
recently begun radiotherapy services in 2017. 
 
The objectives of this study were to identify any differences in time delays in lung cancer 
referral pathways between rural and urban patients and explore patients’ perceived barriers to 
timely lung cancer diagnosis and management.  
 
Methods 
Setting and participants 
Lung cancer patients presenting to Townsville Cancer Centre (TCC), Cairns Base Hospital 
(CBH) and Mackay Base Hospital (MBH) in North Queensland, Australia from 2009 to 2012 
were approached for participation in this prospective study. Patients from Mt. Isa who 
required treatment via teleoncology at the TCC were also included in the study. The study 
was limited to patients from the state of Queensland. The Inclusion criteria specified patients 
diagnosed with lung cancer, age >18years, and a residential address in the study catchment 
area at the time of diagnosis.  Patients electing not to sign consent were excluded from the 
study. Patients were divided into outer regional (urban) and rural or remote (rural) based on 
their residential postcodes and Australian Standard Geographical Classification system 
(ASGC); summarised in Table 1.  
 
Referral times along lung cancer pathway 
The study examined various time frames from estimated date of onset of symptoms to 




T1: Time from first symptoms to commencement of treatment.  
T2: Time between first symptoms to first GP consultation 
T3: Time between GP and specialist consultation 





Clinical data collection 










Data pertaining to treatment and consultation times at TCC, CBH and MBH were extracted 
from their oncology information system MOSAIQ
®
. Outside of cancer centres, data were 




Fisher’s test was used to compare the correlation between ASGC classifications and the 
various time periods. Besides remoteness, influence of other clinical, social and demographic 
factors such as gender, ethnic status (Indigenous or non- Indigenous), education level 
(primary, secondary or tertiary/TAFE), income (<$20,000 or >$20,000), and stage of disease 
on these times were analysed using Kruskal-Wallis and Mann-Whitney tests for statistical 
significance.  
 
Qualitative data collection and analysis 
Semi-structured, open-ended interviews lasting 5-10 minutes were conducted on all 
consenting patients. An interview guide was used in exploring the factors leading to late 
presentations, and poorer outcomes of rural oncology patients in comparison to those living in 
regional or urban areas. A single researcher, who had no clinical involvement and no prior 
relationship with any study participant, conducted interviews. Interviews were undertaken with 
all participants, either face-to-face, over the telephone or via videoconference.  
Each Interview was transcribed, coded, and summarised using thematic analysis. 
 
Ethics approval: 




Our study identified 132 patients from Townsville, 60 from Cairns, 41 from Mackay, 16 from 
Mt Isa and 3 patients referred from private practice. Out of all patients identified, 88% of 
patients were diagnosed with Non-Small Cell Lung Cancer. Further data on demographics 
and diagnoses is presented in Table 2. 
Of the 252 lung cancer patients who participated in the study, 182 (72%) were classified as 
urban and rest as rural/remote. Only two patients declined to participate in this prospective 
study. In rural compared to urban patients there were more males (73.6% vs. 60%, p=0.046) 
and more Caucasians (96.2% vs. 90%, p=0.068). Also, the level of secondary or higher 
education was significantly higher in urban compared to rural cohort (88.5% vs. 62.7%). 
Tumour demographics like histology and stage were balanced between the two cohorts.  
 
Time delays 
Factors associated with time delays at various point in referral pathways were summarised in 
Table 3. Location was associated with delays in T1 and T3. Age and level of educations were 
associated with delays in T2 and stage of the disease was related to T4. Although numerical 
difference seemed large between Indigenous and Non-Indigenous patients in T2, this result 





Patient perspectives of factors contributing to delays 
 
112 patients agreed to take part in short interviews following completion of questionnaires. 
Common themes arising from analyses of transcripts were summarized below: 











Misinterpretation of symptoms by GPs 
 
Misinterpretation of symptoms was considered as a factor in first presentation to the GP 
among rural and urban participants [rural 42% vs. urban 40%]. In addition, it was common 
among participants to delay presentation until their symptoms were severe enough that they 
could not be tolerated or impeded on their day to day activities.  
Some quotes from participants were as follows:  
 
“I went to the GP for other reasons. When he observed me coughing up some blood 
he did an X-ray. Thanks to him the cancer problem was discovered [L010].” 
 
“I didn’t feel good. I kept coughing and I couldn’t ride my bike anymore. I even went 
off the beer.  Probably about 4 months I was like that [L074].” 
 
“I noticed the shortness of breath for more than 9 months. It was getting worse with 
time. I couldn’t sleep, but it did not interfere with my golf. I thought it would get better 
[L026].” 
 
 “I couldn’t lift the drum and the pain my side got really bad [L092].” 
 
 
Many participants described their doctors attributing symptoms to benign causes such as 
infection [rural 26% vs. urban 28%], or exacerbations of co-morbidities [rural 5% vs. urban 
1%].  For example: 
 
“My referral to the specialist was delayed because of my asthma. My doctor thought the 
cough was due to the asthma and treated me with 2-3 courses of antibiotics. When the cough 
did not get better a chest X-ray was done and the lung cancer diagnosis came up [L021].” 
 
Not being doctors’ person 
 
Patients in the rural cohort were more likely to cite the reason of “not being a doctor person” 
for the increased delay in presenting to a GP [rural = 4% vs. urban = 0%].     
 
A number of patients refused investigations such as bronchoscopies. This resulted in further 
delays in diagnosis and management [rural 4% vs. urban 0%]. The reasons for this included 
fear of the investigations, as demonstrated in the quote below from a patient stating “he did 






Competing commitment to family and work 
 
Participants often perceived other priorities as more important than their health, such as 
family commitments and work, leading to delay in presentation [rural 4% vs. urban 0%].  This 
was displayed in this participants’ account: 
 
“I am working hard looking after my handicapped son, that I did not pay attention to my 
cough, and that it had been worsening [L003]”.   
 
Long distance travel and financial difficulties 
 
Participants residing in rural communities frequently described travelling as a significant 
barrier to receiving their chemotherapy and follow up in tertiary centres [rural 15% vs. urban 
0%].  One participant described how she “drove from Mt Isa [L002]”, a distance of 1000km 
from the Townsville Cancer Centre.    
 










Financial difficulty was a central theme reported by rural patients as a key barrier to their 
management [rural 12% vs. urban 5%]. 
 
 “Now there is a problem with me getting to Townsville.  My friend drove me last time 
and I still have not got any petrol money or accommodation money. So I don’t know what to 
do about my next trip on the 25
th
 of November. If it all gets too hard I might let nature take its 
course but if its fixable I would like to be treated [L076]”.  
 
 “I had to give me work up and need a carer now. My wife had to give up her job as 
well [L154].” 
Discussion 
Our prospective study identified several factors associated with referral delays among lung 
cancer patients while adding their perspectives to such delays.  
 
We found that remoteness was associated with delays in onset of symptoms to 
commencement of treatment and GP referral to specialist review. This could be explained by 
poor health seeking behaviour, competing demand on caring for family and work, and cost 
and inconvenience of long distance travel to major centres for appointments and treatment. 
Contrary to the expectation, there was no difference between rural and urban patients in 
onset of symptoms to first GP consultation. Our study did not examine system factors such as 
timely processing of referrals and coordination of multiple appointments within major centres 
that may have contributed to these delays. 
 
The number of indigenous patients was very small in this study (13 indigenous vs. 232 non-
indigenous). Though Indigenous status had no impact on any of the timelines, meaningful 
comparisons were difficult because of smaller number of indigenous patients.  
 
Among lung cancer patients, the literature had described lack of awareness and lack of 
symptom perception as the biggest factors that delay first presentation to GPs. In a study 
conducted by Koyi et. al
8
 in Sweden, it was found that patients did not present early because 
of lack of awareness and difficulty in accessing primary care. Another study conducted in 
England by Bowen et al
9
 identified non-recognition of symptoms as the major cause for 
delayed presentations. Our study identified that at least half of the patients attributed their 
symptoms to benign causes and/or did not recognise their symptoms.  In our study, 61.2% of 
patients presented with stage IV disease and there was no difference between rural and 
regional areas (60.8% in regional vs. 62.1% in rural areas). This was in contrast to a study 
conducted in Scotland, where only 28-33% of patients presented with stage IV disease
4
 and 
patients in rural areas were more likely to present later in the disease process than urban 
areas. Regardless of conflicting results reported by studies, it would be important to improve 




Older age and level of education had an impact on time between first symptoms to first GP 
consultation (T2). Older patients tended to present earlier. This could be explained by the 
presence of multiple co-morbidities in elderly patients and the need to visit GPs regularly and 
thus were better educated in their symptom recognition. Though the level of secondary or 
high school education was lower among rural patients in our study, location of residence was 
not related to delays in T2 in contrast to the Western Australian study.
3
 It was possible that 
there might be differences between patients from capital cities such as Perth and regional 




One of the issues expressed by rural patients in our study was the limited access to care 
closer to home and resulting inconvenience and cost of long distance travel to attend 
appointments and treatment. This issue was compounded by the fact that some patients had 
to simultaneously manage their family and work commitments while undergoing medical 










therapies. Hopefully, adoption of various teleoncology and telehealth models of care by health 
systems to improve rural access to all aspects of patient journey may alleviate some of the 
burden and enable rural patients attend appointments and treatment in a timely manner.
10  
 
Though our study was a prospective study, date of onset of symptom was based on patients’ 
recollection. However, patients’ recollection in our study would be more accurate at the time 
of presentation than that of retrospective studies where patients were expected to remember 
events after multiple encounters with multiple specialists and treatment providers. Our study 
also failed to investigate system deficiencies within larger centres that may have contributed 
to delays. Some of these deficiencies could include chaotic referral processes and lack of 
coordination of multiple appointments. Consistent use of cancer care coordinators and 
adherence to lung cancer optimal care pathways could minimise system deficiencies. 
 
In conclusion, our study, while confirming remoteness, age and level of education as factors 
associated with delays in lung cancer referral pathways, highlighted issues faced by patients 
that may contribute to these delays. Educational campaigns aimed at improving symptom 
recognition among all populations (both rural and regional) and creation of systems to provide 
specialist services closer to home for rural patients may decrease some of the delays.  
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Table 1: Separation of patients based on postcodes.  
 
Cohort as per ASGC classification Urban/Outer regional 
(RA 3) 
Rural/Remote 
(RA 4 and 5) 
City (Postcodes) Townsville (4810-4817) All other areas were under this 
classification Cairns (4868-4871) 
Mackay (4739-4741) 
 
Table 2: Demographic details of participants 
 
Characteristics Total N=252(%) Outer regional N=182(%) Remote or very remote N=70(%) p-value** 
Demographic 
Male 176 (69.8%) 134 (73.6%) 42 (60.0%) P=0.046 
Mean age (SD); range [years] 65.2 (10.0); 37 to 91 65.5 (10.5); 37 to 91 64.5 (8.7); 38 to 81 p=0.482 
Indigenous patients 14 (5.6%) 7 (3.8%) 7 (10.0%) P=0.068 
Born in Australia 205 (81.3%) 148 (81.3%) 57 (81.4%) P=1.0 
Secondary or higher school education 109 (79.0%) 77 (88.5%) 32 (62.7%) P=0.003 
Private health insurance 81 (32.1%) 61 (33.5%) 20 (28.6%) P=0.018 
Income less than $20,000 70 (54.7%) 48 (60.0%) 22 (45.8%) P=0.144 
Diagnosis 
Incidental finding 51 (20.2%) 44 (24.2%) 7 (10.0%) P=0.014 
Small cell lung cancer 29 (11.5%) 20 (11%) 9 (12.9%) P=0.664 





% Treatment palliative  190 (75.4%) 138 (75.8%) 52 (74.3%) P=0.870 
 
 
Table 3: Factors contributing to delays at various time points in referral pathways.  




















T1 – Time between first symptoms to treatment  
Location Townsville (n=81) Cairns and Mackay (n=60) Remote (n=111) p-value 
Median delay; (days);  125; (21-465) 148; (21-689) 170; (32-938) 0.040 
T2 – Time between first symptoms to first GP consultation 
Indigenous status Indigenous Non- Indigenous  p-value 
Mean delay; range (days);  92; (14-242) 57; (0-905)  0.055 
Age group 31 to 50 51 - 70 >71 p-value 
Median delay; range (days);  14; (0-150) 61; (0-881) 45; (0-905) 0.026 
Level of education Maximal primary Secondary Tertiary or TAFE p-value 
Median delay; range (days);  91; (0-905) 61; (0-881) 23; (0-367) 0.023 
T3 – Time delay between first GP consultation and first specialist consultation 
Location Townsville Cairns or Mackay Remote p-value 
Median delay; range (days);  15; (0-401) 14; (0-364) 29.5; (0-389) 0.041 
T4 – Time between first specialist consultation and treatment commencement 
Stage of disease Stage I Stage II Stage III Stage IV p-value 
Median delay; range (days);  21;(0-105) 11; (0-364) 34; (0-643) 18; (0-257) 0.031 
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